Panion & BF Biotech Inc (1760) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.039x

Based on the latest financial reports, Panion & BF Biotech Inc (1760) has a cash flow conversion efficiency ratio of 0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$73.31 Million ≈ $2.31 Million USD) by net assets (NT$1.90 Billion ≈ $59.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Panion & BF Biotech Inc - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Panion & BF Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Panion & BF Biotech Inc debt and liabilities for a breakdown of total debt and financial obligations.

Panion & BF Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Panion & BF Biotech Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Photocure OL:PHO	0.054x
Shangri-La Hotel Public Company Limited BK:SHANG	0.013x
VAA Vista Alegre Atlantis SGPS SA LS:VAF	0.066x
Dynacor Gold Mines Inc. TO:DNG	0.011x
Solid FAB ST:SFAB	0.072x
PIE Industrial Bhd KLSE:7095	0.036x
Namsun Alumini KO:008350	-0.005x
Maschinenfabrik Berthold Hermle AG F:MBH3	0.092x

Annual Cash Flow Conversion Efficiency for Panion & BF Biotech Inc (2009–2024)

The table below shows the annual cash flow conversion efficiency of Panion & BF Biotech Inc from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see Panion & BF Biotech Inc (1760) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$1.92 Billion ≈ $60.56 Million	NT$351.19 Million ≈ $11.06 Million	0.183x	+96.80%
2023-12-31	NT$1.91 Billion ≈ $60.21 Million	NT$177.42 Million ≈ $5.59 Million	0.093x	-61.96%
2022-12-31	NT$2.01 Billion ≈ $63.24 Million	NT$489.87 Million ≈ $15.43 Million	0.244x	+17.59%
2021-12-31	NT$1.93 Billion ≈ $60.90 Million	NT$401.23 Million ≈ $12.64 Million	0.208x	+1868.28%
2020-12-31	NT$1.24 Billion ≈ $39.07 Million	NT$-14.55 Million ≈ $-458.56K	-0.012x	-117.54%
2019-12-31	NT$1.36 Billion ≈ $42.83 Million	NT$90.98 Million ≈ $2.87 Million	0.067x	+15.01%
2018-12-31	NT$1.35 Billion ≈ $42.55 Million	NT$78.58 Million ≈ $2.48 Million	0.058x	-57.36%
2017-12-31	NT$835.25 Million ≈ $26.31 Million	NT$113.97 Million ≈ $3.59 Million	0.136x	-37.91%
2016-12-31	NT$806.41 Million ≈ $25.41 Million	NT$177.22 Million ≈ $5.58 Million	0.220x	+192.12%
2015-12-31	NT$775.03 Million ≈ $24.42 Million	NT$58.30 Million ≈ $1.84 Million	0.075x	-29.74%
2014-12-31	NT$710.84 Million ≈ $22.40 Million	NT$76.11 Million ≈ $2.40 Million	0.107x	-18.47%
2013-12-31	NT$656.55 Million ≈ $20.68 Million	NT$86.22 Million ≈ $2.72 Million	0.131x	+825.27%
2012-12-31	NT$278.86 Million ≈ $8.79 Million	NT$3.96 Million ≈ $124.70K	0.014x	+111.67%
2011-12-31	NT$296.98 Million ≈ $9.36 Million	NT$-36.12 Million ≈ $-1.14 Million	-0.122x	-164.01%
2010-12-31	NT$301.62 Million ≈ $9.50 Million	NT$-13.89 Million ≈ $-437.77K	-0.046x	-119.43%
2009-12-31	NT$324.61 Million ≈ $10.23 Million	NT$76.98 Million ≈ $2.43 Million	0.237x	--

About Panion & BF Biotech Inc

TW:1760 Taiwan Biotechnology

Market Cap

$184.23 Million

NT$5.85 Billion TWD

Market Cap Rank

#16847 Global

#833 in Taiwan

Share Price

NT$68.20

Change (1 day)

-0.29%

52-Week Range

NT$58.80 - NT$83.60

All Time High

NT$228.22